what is semaglutide compound made of | C187H291N45O59 | CID 56843331 Mix-it-yourself Wegovy? Some try risky

Zepbound (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

But there are creative, albeit unapproved ways of injecting less medication than the manufacturers intended

It is studied for its potent effects on weight loss, metabolic regulation, and insulin sensitivity

According to the Centers for Disease Control and Prevention, 26.5% of adults with diagnosed diabetes used GLP-1 injections in 2024

Honest disclosure of all health conditions, surgeries, and family medical history is essential for safe candidacy determination

Early research suggested GIP might promote fat storage, which initially made scientists skeptical about using GIP agonists for weight loss